secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-06-11T20:15:23+00:00
Accession:  0001493152-26-028283
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech prices $2.65 million registered direct offering and private placement
--------------------------------------------------------------------------------

- Company issued 2,554,119 registered shares and 771,503 unregistered shares at $0.5189 per share for gross proceeds of ~$2.65M.
- Also issued pre-funded warrants for 1,782,616 shares at $0.001 exercise price and Class J warrants for 10,216,476 shares at $0.5189.
- Offering includes placement agent warrants for 306,494 shares at $0.6486 per share; Ladenburg Thalmann acted as placement agent.
- Net proceeds will fund clinical trial activities, manufacture of clinical drug supply, and working capital.
- Closing expected on or about June 10, 2026, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226028283/0001493152-26-028283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226028283/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer